期刊
ONCOGENE
卷 29, 期 18, 页码 2605-2615出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.88
关键词
RUNX3; tumor suppressor; solid tumors; functional inactivation; TGF-beta; Wnt
资金
- Ministry of Education (MOE)
- National Research Foundation (NRF), Singapore
The study of RUNX3 in tumor pathogenesis is a rapidly expanding area of cancer research. Functional inactivation of RUNX3-through mutation, epigenetic silencing, or cytoplasmic mislocalization-is frequently observed in solid tumors of diverse origins. This alone indicates that RUNX3 inactivation is a major risk factor in tumorigenesis and that it occurs early during progression to malignancy. Conversely, RUNX3 has also been described to have an oncogenic function in a subset of tumors. Although the mechanism of how RUNX3 switches from tumor suppressive to oncogenic activity is unclear, this is of clinical relevance with implications for cancer detection and prognosis. Recent developments have significantly contributed to our understanding of the pleiotropic tumor suppressive properties of RUNX3 that regulate major signaling pathways. This review summarizes the important findings that link RUNX3 to tumor suppression. Oncogene (2010) 29, 2605-2615; doi:10.1038/onc.2010.88; published online 29 March 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据